Loading data for PRVA — first visit, this takes a few seconds.

Preisalarm

Privia Health Group Inc. (PRVA)

NasdaqGS: PRVA · Echtzeitkurs · USD

21.12

-0.08 (-0.38%)

Zum Schluss: Aug 21, 2026, 3:59 PM

21.24

+0.57%

Nachbörslich: 7:39 PM

Kurs, die wichtigsten Kennzahlen und die neuesten Nachrichten an einem Ort.

-0.38% (1D)

Geld	15.12
Marktkapitalisierung	2.7 Mrd
Umsatz (TTM)	2.36 Mrd
Nettogewinn (TTM)	28.12 Mio
	0.90
	0.22
	96
	19.86
KBV (TTM)	3.41
KUV (TTM)	1.14
Termin Quartalszahlen	Nov 5, 2026

Brief	26.98
Volumen	871,544
Ø Vol. (20D)	1,188,385
Eröffnung	21.22
Vortagesschluss	21.20
Tagesspanne	21.04 - 21.34
52-Wk Range	19.53 - 28.82
Analyst	n/a
Kursziel	n/a
Dividenden	n/a
Ex-Dividenden-Datum	n/a

Über PRVA

Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with physician practices, health plans, and health systems. It also offers technology and population health tools to enhance providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; and single-TIN medical group that facilitates negotiating power...

[Mehr lesen]

Branche Health Information Services

Sektor Healthcare

IPO Datum Apr 28, 2021

Mitarbeiter 1,226

Börse NasdaqGS

Tickersymbol PRVA

Website https://www.priviahealth.com

Vollständiges Unternehmensprofil

Finanzielle Entwicklung

Im Jahr 2025 betrug der Umsatz von Privia Health 2.12 Mrd, ein Anstieg von 22.26% im Vergleich zum Vorjahr (1.74 Mrd). Der Gewinn lag bei 22.92 Mio, ein Anstieg von 59.33 %.

Finanzberichte

Gewinnüberraschung

Privia Health hat die Quartalszahlen am Aug 6, 2026 veröffentlicht:

Umsatz von $632.63 Mio verfehlt die Erwartungen um $0, mit 21.39% Wachstum im Jahresvergleich.

EPS von 0.19 verfehlt die Erwartungen um -0.05, mit -20.83% Rückgang im Jahresvergleich.

Nächste Ergebnisveröffentlichung

Privia Health Group Inc. wird voraussichtlich die Quartalszahlen veröffentlichen am Nov 5, 2026, vor Börseneröffnung.
Analysten erwarten einen Umsatz von ... Upgrade

Nachrichten

vor 1 Tag · StockStory

Privia Health (PRVA): Buy, Sell, or Hold Post Q2 Earnings?

Privia Health has been treading water for the past six months, recording a small loss of 1.7% while holding steady at $21.63. The stock also fell short of the S&P 500’s 11.3% gain during that period.

vor 6 Tagen · StockStory

The Top 5 Analyst Questions From Privia Health’s Q2 Earnings Call

Privia Health’s second quarter results were met with a negative market reaction as investors digested the company’s strong revenue growth alongside a material shortfall in non-GAAP profit relative to ...

vor 1 Woche · Insider Monkey

Privia Health’s (PRVA) Guidance Keeps Rising, So Is The Stock Keeping Pace?

Privia Health (NASDAQ:PRVA) just turned in a quarter that checked every box management set for itself, and then raised the bar again for the rest of the year. On the company’s August 6 earnings call, ...

vor 1 Woche · Motley Fool

Privia Health (PRVA) Q2 2026 Earnings Call Transcript

Net income surged 237% while attributed lives grew 19%, signaling strong operational momentum.

vor 1 Woche · StockStory

PRVA Q2 Deep Dive: Revenue Growth Outpaces Profit as Margin Expansion Remains in Focus

Healthcare tech company Privia Health Group (NASDAQ:PRVA) beat Wall Street’s revenue expectations in Q2 CY2026, with sales up 21.4% year on year to $632.6 million. Its non-GAAP profit of $0.19 per sha...

Seite 1 von 2

Privia Health Group Inc. (PRVA)